---
title: "ZHEJIANG ZHENYUAN: Expected net profit in 2024 to decline by 55.2%-68% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225354880.md"
description: "ZHEJIANG ZHENYUAN expects its net profit in 2024 to decline by 55.2%-68% year-on-year, with the net profit attributable to shareholders of the listed company expected to be between 26.1256 million yuan and 36.5759 million yuan. The net profit after deducting non-recurring gains and losses is expected to be between 20.3352 million yuan and 28.4693 million yuan, with basic earnings per share expected to be between 0.08 yuan/share and 0.11 yuan/share. The performance change is mainly affected by factors such as the contraction of the pharmaceutical wholesale business scale, an increase in accounts receivable, and an increase in financial expenses"
datetime: "2025-01-17T12:55:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225354880.md)
  - [en](https://longbridge.com/en/news/225354880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225354880.md)
generator: "portal-rs"
---

# ZHEJIANG ZHENYUAN: Expected net profit in 2024 to decline by 55.2%-68% year-on-year

ZHEJIANG ZHENYUAN announced that from January 1, 2024, to December 31, 2024, the net profit attributable to shareholders of the listed company is expected to be between 26.1256 million yuan and 36.5759 million yuan, a decrease of 55.2% to 68% compared to the same period last year. The net profit after deducting non-recurring gains and losses is expected to be between 20.3352 million yuan and 28.4693 million yuan, a decrease of 63.6% to 74% compared to the same period last year. The basic earnings per share are expected to be between 0.08 yuan/share and 0.11 yuan/share. The company's performance changes are mainly due to factors such as the contraction of the pharmaceutical wholesale business scale, an increase in accounts receivable, and an increase in financial expenses

### Related Stocks

- [000705.CN](https://longbridge.com/en/quote/000705.CN.md)
- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [002727.CN](https://longbridge.com/en/quote/002727.CN.md)
- [301096.CN](https://longbridge.com/en/quote/301096.CN.md)
- [600998.CN](https://longbridge.com/en/quote/600998.CN.md)

## Related News & Research

- [Week ahead for FX, bonds: All eyes on Fed rate decision](https://longbridge.com/en/news/298752509.md)
- [Palliser Capital Increases Stake in WUS Taiwan to Over 5% Following Constructive Engagement with Management](https://longbridge.com/en/news/298441696.md)
- [REG - American Century Inv SThree plc - Form 8.3 - SThree PLC](https://longbridge.com/en/news/298609616.md)
- [Is Apple Finally About to Become an AI Stock? Does That Make AAPL A Buy?](https://longbridge.com/en/news/298470046.md)
- [Eurozone bond yields rise; 10-year Bund yield hits new 15-year high](https://longbridge.com/en/news/298699656.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**